Enliven Therapeutics shares owned by Mirae Asset Global Investments
Quarter-by-quarter ownership of Enliven Therapeutics (ELVN) shares owned by Mirae Asset Global Investments
from 13F filings
Historical chart of Mirae Asset Global Investments investment in Enliven Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Enliven Therapeutics held by Mirae Asset Global Investments consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Enliven Therapeutics by Mirae Asset Global Investments
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $47k | 2.3k | 20.47 |
| 2025-06-30 | $38k | 1.9k | 20.06 |
| 2025-03-31 | $34k | 1.6k | 21.07 |
| 2024-12-31 | $36k | 1.6k | 22.37 |
| 2024-09-30 | $41k | 1.7k | 24.13 |
| 2024-06-30 | $33k | 1.4k | 23.45 |
| 2023-12-31 | $170k | 12k | 13.84 |
| 2023-09-30 | $154k | 11k | 13.66 |
| 2023-06-30 | $230k | 11k | 20.41 |
More positions owned by Mirae Asset Global Investments
View all positions for Mirae Asset Global Investments